Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: A synthesis of genetic association studies

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages 169-176

  Zintzaras, Elias ^a,b   Doxani, Chrysoula ^a,c   Rodopoulou, Paraskevi ^a   Bakalos, Georgios ^a   Ziogas, Dimitris C ^d   Ziakas, Panayiotis ^c   Voulgarelis, Michael ^c  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

A1298C; Acute lymphoblastic leukemia; ALL; C677T; Gene; Genetic association; Meta analysis; MTHFR; Polymorphism; Risk; Susceptibility

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CHILDHOOD CANCER; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT;

CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84858798304     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.10.002     Document Type: Article

References (59)

1. Altekruse S.F., Kosary C.L., Krapcho M., Neyman N., Aminou R., Waldron W., et al. SEER cancer statistics review, 1975-2007 2007, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2. Pui C.H., Robison L.L., Look A.T. Acute lymphoblastic leukaemia. Lancet 2008, 371(9617):1030-1043.
3. Ziegelberger G., Dehos A., Grosche B., Hornhardt S., Jung T., Weiss W. Childhood leukemia - risk factors and the need for an interdisciplinary research agenda. Prog Biophys Mol Biol 2011, September 19 [Epub ahead of print].
4. Lightfoot T.J., Roman E. Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 2004, 199(2):104-117.
5. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997, 94(7):3290-3295.
6. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10(1):111-113.
7. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998, 64(3):169-172.
8. Zintzaras E., Koufakis T., Ziakas P.D., Rodopoulou P., Giannouli S., Voulgarelis M. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol 2006, 21(7):501-510.
9. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006, 51(7):618-624.
10. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 2006, 69(4):327-336.
11. Zintzaras E., Uhlig K., Koukoulis G.N., Papathanasiou A.A., Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 2007, 52(11):881-890.
12. Choi S.W., Mason J.B. Folate and carcinogenesis: an integrated scheme. J Nutr 2000, 130(2):129-132.
13. Shrubsole M.J., Gao Y.T., Cai Q., Shu X.O., Dai Q., Hébert J.R., et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004, 13(2):190-196.
14. Chiusolo P., Reddiconto G., Cimino G., Sica S., Fiorini A., Farina G., et al. Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 2004, 89(2):139-144.
15. Kelemen L.E., Sellers T.A., Schildkraut J.M., Cunningham J.M., Vierkant R.A., Pankratz V.S., et al. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008, 68(7):2498-2506.
16. Zintzaras E. Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies. Biomarkers 2010, 15(1):69-79.
17. Pereira T.V., Rudnicki M., Pereira A.C., Pombo-de-Oliveira M.S., Franco R.F. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15(10):1956-1963.
18. Trikalinos T.A., Salanti G., Zintzaras E., Ioannidis J.P. Meta-analysis methods. Adv Genet 2008, 60:311-334.
19. Zintzaras E., Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet 2008, 53(1):1-9.
20. Lau J., Antman E.M., Jimenez-Silva J., Kupelnick B., Mosteller F., Chalmers T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992, 327(4):248-254.
21. Zintzaras E. Variance estimation of allele-based odds ratio in the absence of Hardy-Weinberg equilibrium. Eur J Epidemiol 2008, 23(5):323-326.
22. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
23. Munafo M.R., Flint J. Meta-analysis of genetic association studies. Trends Genet 2004, 20(9):439-444.
24. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
25. Harbord R.M., Egger M., Sterne J.A. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006, 25(20):3443-3457.
26. Wiemels J.L., Smith R.N., Taylor G.M., Eden O.B., Alexander F.E., Greaves M.F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A 2001, 98(7):4004-4009.
27. Lightfoot T.J., Johnston W.T., Painter D., Simpson J., Roman E., Skibola C.F., et al. Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood 2010, 115(19):3923-3929.
28. Balta G., Yuksek N., Ozyurek E., Ertem U., Hicsonmez G., Altay C., et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003, 73(3):154-160.
29. Lv L., Wu C., Sun H., Zhu S., Yang Y., Chen X., et al. Combined 677CC/1298AC genotypes of methylenetetrahydrofolate reductase (MTHFR) reduce susceptibility to precursor B lymphoblastic leukemia in a Chinese population. Eur J Haematol 2010, 84(6):506-512.
30. Thirumaran R.K., Gast A., Flohr T., Burwinkel B., Bartram C., Hemminki K., et al. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 2005, 106(7):2590-2591. author reply 2591-2.
31. Oliveira E., Alves S., Quental S., Ferreira F., Norton L., Costa V., et al. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 2005, 27(8):425-429.
32. Reddy H., Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 2006, 47(7):1333-1339.
33. Kim N.K., Chong S.Y., Jang M.J., Hong S.H., Kim H.S., Cho E.K., et al. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 2006, 26(4B):2879-2881.
34. Giovannetti E., Ugrasena D.G., Supriyadi E., Vroling L., Azzarello A., de Lange D., et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk Res 2008, 32(1):19-24.
35. Alcasabas P., Ravindranath Y., Goyette G., Haller A., Del Rosario L., Lesaca-Medina M.Y., et al. 5,10-Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer 2008, 51(2):178-182.
36. Damnjanovic T., Milicevic R., Novkovic T., Jovicic O., Bunjevacki V., Jekic B., et al. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children. J Pediatr Hematol Oncol 2010, 32(4):e148-e150.
37. Sood S., Das R., Trehan A., Ahluwalia J., Sachdeva M.U., Varma N., et al. Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians. Leuk Lymphoma 2010, 51(5):928-932.
38. Sadananda Adiga M.N., Chandy S., Ramachandra N., Appaji L., Aruna Kumari B.S., Ramaswamy G., et al. Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children. Indian J Cancer 2010, 47(1):40-45.
39. Chan J.Y., Ugrasena D.G., Lum D.W., Lu Y., Yeoh A.E. Xenobiotic and folate pathway gene polymorphisms and risk of childhood acute lymphoblastic leukaemia in Javanese children. Hematol Oncol 2011, 29(3):116-123. Epub 2010 Sep 7.
40. Krajinovic M., Lamothe S., Labuda D., Lemieux-Blanchard E., Theoret Y., Moghrabi A., et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004, 103(1):252-257.
41. Schnakenberg E., Mehles A., Cario G., Rehe K., Seidemann K., Schlegelberger B., et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005, 6:23.
42. Chatzidakis K., Goulas A., Athanassiadou-Piperopoulou F., Fidani L., Koliouskas D., Mirtsou V. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in Greek patients. Pediatr Blood Cancer 2006, 47(2):147-151.
43. Petra B.G., Janez J., Vita D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk Lymphoma 2007, 48(4):786-792.
44. de Jonge R., Tissing W.J., Hooijberg J.H., Jansen G., Kaspers G.J., Lindemans J., et al. Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009, 113(10):2284-2289.
45. Karathanasis N.V., Stiakaki E., Goulielmos G.N., Kalmanti M. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia. Genet Test Mol Biomarkers 2010, 15(1-2):5-10.
46. Yeoh A.E., Lu Y., Chan J.Y., Chan Y.H., Ariffin H., Kham S.K., et al. Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group. Leuk Res 2010, 34(3):276-283.
47. Tong N., Fang Y., Li J., Wang M., Lu Q., Wang S., et al. Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci 2010, 101(3):782-786.
48. Franco R.F., Simoes B.P., Tone L.G., Gabellini S.M., Zago M.A., Falcao R.P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001, 115(3):616-618.
49. Zanrosso C.W., Hatagima A., Emerenciano M., Ramos F., Figueiredo A., Félix T.M., et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 2006, 30(4):477-481.
50. Kamel A.M., Moussa H.S., Ebid G.T., Bu R.R., Bhatia K.G. Synergistic effect of methyltetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric acute lymphoblastic leukemia. J Egypt Natl Canc Inst 2007, 19(2):96-105.
51. Lau J., Ioannidis J.P., Terrin N., Schmid C.H., Olkin I. The case of the misleading funnel plot. BMJ 2006, 333(7568):597-600.
52. http://www.hapmap.org/.
53. Chapman J., Clayton D. Detecting association using epistatic information. Genet Epidemiol 2007, 31(8):894-909.
54. Clayton D., McKeigue P.M. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001, 358(9290):1356-1360.
55. Blencowe H., Cousens S., Modell B., Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010, 39(Suppl. 1):i110-i121.
56. Malinow M.R., Duell P.B., Hess D.L., Anderson P.H., Kruger W.D., Phillipson B.E., et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998, 338(15):1009-1015.
57. Choumenkovitch S.F., Selhub J., Wilson P.W., Rader J.I., Rosenberg I.H., Jacques P.F. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002, 132(9):2792-2798.
58. Mason J.B., Dickstein A., Jacques P.F., Haggarty P., Selhub J., Dallal G., et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007, 16(7):1325-1329.
59. Ulrich C.M. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 2007, 86(2):271-273.